文献速递乳腺技术与安全PETMR

PET/MRI与生物发光成像识别缺氧是三阴性乳腺癌程序性细胞死亡配体1影像异质性的原因

PET/MRI and Bioluminescent Imaging Identify Hypoxia as a Cause of Programmed Cell Death Ligand 1 Image Heterogeneity.
PubMed 文献 · Radiol Imaging Cancer · 2023-01-01

研究在同系小鼠三阴性乳腺癌模型中用PET/MRI与生物发光成像观察缺氧与PD-L1表达的空间关联,发现缺氧区域与PD-L1表达增高空间上密切关联,缺氧处理的鼠源和人源三阴性乳腺癌细胞PD-L1表达显著增加,癌症基因组图谱分析进一步支持缺氧升高PD-L1表达。

要点

  • 缺氧区域与PD-L1表达增高在空间上密切关联。
  • 缺氧暴露使鼠源和人源三阴性乳腺癌细胞PD-L1表达显著增加。
  • 癌症基因组图谱分析支持缺氧升高PD-L1表达。

核心结论

  • 缺氧可能通过增加癌细胞PD-L1表达参与肿瘤内PD-L1异质性。

研究设计与样本

  • 同系小鼠三阴性乳腺癌模型研究,采用PET/MRI与光学成像,并以在缺氧条件下表达荧光素酶的同系三阴性乳腺癌模型进行观察。

关键影像表现/征象

  • 在同系小鼠4T1肿瘤模型中,缺氧区域与PD-L1表达增高区域空间上密切关联。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Purpose To examine the association between hypoxia and programmed cell death ligand 1 (PD-L1) expression using bioluminescence imaging (BLI) and PET/MRI in a syngeneic mouse model of triple-negative breast cancer (TNBC). Materials and Methods PET/MRI and optical imaging were used to determine the role of hypoxia in altering PD-L1 expression using a syngeneic TNBC model engineered to express luciferase under hypoxia. Results Imaging showed a close spatial association between areas of hypoxia and increased PD-L1 expression in the syngeneic murine (4T1) tumor model. Mouse and human TNBC cells exposed to hypoxia exhibited a significant increase in PD-L1 expression, consistent with the in vivo imaging data. The role of hypoxia in increasing PD-L1 expression was further confirmed by using The Cancer Genome Atlas analyses of different human TNBCs. Conclusion These results have identified the potential role of hypoxia in contributing to PD-L1 heterogeneity in tumors by increasing cancer cell PD-L1 expression. Keywords: Hypoxia, PD-L1, Triple-Negative Breast Cancer, PET/MRI, Bioluminescence Imaging Supplemental material is available for this article. © RSNA, 2023.

来源:Radiol Imaging Cancer,查看原文。版权归原作者所有。

引用

  1. Parkins KM, Krishnamachary B, Jacob D, et al. PET/MRI and Bioluminescent Imaging Identify Hypoxia as a Cause of Programmed Cell Death Ligand 1 Image Heterogeneity. Radiol Imaging Cancer. 2023. PMID: 37389448. doi:10.1148/rycan.220138

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。